Part 7/13:
Public perception and trust play crucial roles. Some individuals in Singapore and Hong Kong prefer Sinovac because of its traditional platform, perceiving it as proven and reliable, especially for those with allergies to mRNA ingredients. Additionally, concerns about long-term safety of newer technologies make inactivated vaccines appealing.
Moreover, in certain regions like Hong Kong, Sinovac has been administered extensively over the years, fueling confidence among residents and healthcare providers alike. The familiarity of inactivated vaccines, coupled with a perceived safety advantage, drives demand even in countries where mRNA vaccines are more prevalent.